Working in collaboration with Oregon’s university medical schools, hospitals and clinical research centers, biopharmaceutical companies are conducting or have conducted since 1999 more than 2,300 clinical trials of new medicines in the state, a released today shows.
February 1, 2012 -- Dr. Kent Thornburg, who teaches in the Division of Cardiovascular Medicine at Oregon Health & Science University and is known worldwide for his research into the developmental origins of disease – has been named interim director of the Bob and Charlee Moore Institute for Nutrition and Wellness, a new research and education center.
January 19, 2012 -- Oregon Health & Science University has joined the University Partnership of BioPontis Alliance, becoming the ninth premier institution engaged in the partnership to improve how discoveries made in laboratories at academic research centers translate into public benefit.
January 18, 2012 -- As policymakers wrestle with transforming Oregon’s healthcare system to control costs and improve quality, competition stands in the way, according to Dr. Charles Kilo, chief medical officer at Oregon Health & Science University.
December 6, 2011 – Oregon Health & Science University intends to restructure approximately $210 million of its variable rate debt, and replace old auction rate debt with a more stable funding structure following Friday’s board meeting.
Chief Financial officer Lawrence Furnstahl had urged the board to take advantage of favorable conditions -- annual fees for credit will drop by two-thirds, from 1.80 percent to less than .60 percent for a three-year commitment, saving the university approximately $2 million a year.
December 5, 2011 -- Yale School of Medicine has chosen the Oregon Evidence-based Practice Center at Oregon Health & Science University as one of two research centers that will independently review all clinical studies of a controversial product used in spinal surgeries to promote bone growth.
The selection of the Oregon Evidence-based Practice Center comes after Yale had entered into an unusual agreement with Medtronic, the manufacturer of the bone growth product — called bone morphogenetic protein-2 — to independently review the product.
December 5, 2011 == The first federally funded report to compare children with special health care needs to children without reveals 14 percent to 19 percent of children in the United States have a special health care need and their insurance is inadequate to cover the greater scope of care they require for optimal health.
November 30, 2011 -- Researchers at OHSU are developing a toolkit to deal with the barriers faced by people with autism in the healthcare system.
November 16, 2011 -- Surveys of doctors show that now more than half think that providing higher-quality medicine may lead to losses in their earning power, a belief that may help explain why an exceptionally high number of patients don’t get recommended care, according to Dr. David Reuben MD, who spoke at the OHSU Foundation for Medical Excellence annual lecture earlier this week.